Security key
140755208
TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA)
CUSIP: 140755208
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 9,346,119
- Total 13F shares
- 22,165
- Share change
- +236
- Total reported value
- $862,745
- Reported price per share
- $39.00
- Number of holders
- 8
- Value change
- +$8,201
- Number of buys
- 3
Security identity
Holder snapshot
Report period
Q3 2025
Institutions
8
Top holders
8
CARA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Tvardi Therapeutics, Inc. SEC filings
Tvardi Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 140755208
Recent filing periods:
Ownership snapshot
Top reported holders of CARA - TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Sporos Bioventures LLC
13D/G signal
Sporos Bioventures LLC
Evidence rows
15
Latest as of
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 9%
13D/G row: Sporos Bioventures LLC
Showing 1-6 of 15 holder rows.
Rank 1 holder
Sporos Bioventures LLC
13D/G
- Ownership
- 9%
- Position
- $19.54M
Rank 2 holder
Solas Tvardi Sidecar LLC
13D/G
- Ownership
- 8.1%
- Position
- $4.05M
Rank 3 holder
Slate Path Capital LP
13D/G
13F
- Ownership
- 7.5%
- Position
- $19.26M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sporos Bioventures LLC |
13D/G
|
9%
|
$19,544,812
837,636 shares
|
$0 | 15 Apr 2025 |
| Solas Tvardi Sidecar LLC |
13D/G
|
8.1%
|
$4,050,047
761,287 shares
|
$0 | 15 Apr 2025 |
| Slate Path Capital LP |
13D/G
13F
Company
|
7.5%
|
$19,257,627
704,118 shares
|
$0 | 30 Jun 2025 |
| David J. Tweardy |
13D/G
|
7%
|
$3,470,757
652,398 shares
|
$0 | 15 Apr 2025 |
| Ronald A. DePinho |
13D/G
|
6.7%
|
$24,413,770
626,190 shares
|
-$6,035,311 | 30 Sep 2025 |
| Samuel D. Tweardy |
13D/G
|
3.4%
|
$7,365,343
315,658 shares
|
-$14,730,686 | 07 Jul 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
22,165
Rows available
8
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
7
Q3 2025 holders
8
Holder diff
1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend